Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Neurovascular Devices Market, by End User
1.4.2 North America Neurovascular Devices Market, by Technology
1.4.3 North America Neurovascular Devices Market, by Disease Pathology
1.4.4 North America Neurovascular Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Neurovascular Devices Market by End User
3.1 North America Hospital & Surgery Centers Market by Country
3.2 North America Ambulatory Care Centers Market by Country
3.3 North America Research laboratories & Academic Institutes Market by Country
Chapter 4. North America Neurovascular Devices Market by Technology
4.1 North America Embolization & Coiling Market by Country
4.2 North America Neurovascular Devices Market by Embolization & Coiling Type
4.2.1 North America Embolic Coils Market by Country
4.2.2 North America Flow Diversion Devices Market by Country
4.2.3 North America Liquid Embolic Agents Market by Country
4.3 North America Neurothrombectomy Devices Market by Country
4.4 North America Neurovascular Devices Market by Neurothrombectomy Devices Type
4.4.1 North America Clot Retrievers Market by Country
4.4.2 North America Suction & Aspiration Devices Market by Country
4.4.3 North America Snares Market by Country
4.5 North America Cerebral Balloon Angioplasty & Stenting Systems Market by Country
4.6 North America Neurovascular Devices Market by Cerebral Balloon Angioplasty & Stenting Systems Type
4.6.1 North America Carotid Artery Stents Market by Country
4.6.2 North America Embolic Protection Systems Market by Country
4.7 North America Support Devices Market by Country
4.8 North America Neurovascular Devices Market by Support Devices Type
4.8.1 North America Microcatheters Market by Country
4.8.2 North America Microguidewires Market by Country
Chapter 5. North America Neurovascular Devices Market by Disease Pathology
5.1 North America Cerebral Aneuryms Market by Country
5.2 North America Ischemic Strokes Market by Country
5.3 North America Cartoid Artery Stenosis Market by Country
5.4 North America Arteriovenous Malformation & Fistulas (AVM) Market by Country
5.5 North America Others Market by Country
Chapter 6. North America Neurovascular Devices Market by Country
6.1 US Neurovascular Devices Market
6.1.1 US Neurovascular Devices Market by End User
6.1.2 US Neurovascular Devices Market by Technology
6.1.2.1 US Neurovascular Devices Market by Embolization & Coiling Type
6.1.2.2 US Neurovascular Devices Market by Neurothrombectomy Devices Type
6.1.2.3 US Neurovascular Devices Market by Cerebral Balloon Angioplasty & Stenting Systems Type
6.1.2.4 US Neurovascular Devices Market by Support Devices Type
6.1.3 US Neurovascular Devices Market by Disease Pathology
6.2 Canada Neurovascular Devices Market
6.2.1 Canada Neurovascular Devices Market by End User
6.2.2 Canada Neurovascular Devices Market by Technology
6.2.2.1 Canada Neurovascular Devices Market by Embolization & Coiling Type
6.2.2.2 Canada Neurovascular Devices Market by Neurothrombectomy Devices Type
6.2.2.3 Canada Neurovascular Devices Market by Cerebral Balloon Angioplasty & Stenting Systems Type
6.2.2.4 Canada Neurovascular Devices Market by Support Devices Type
6.2.3 Canada Neurovascular Devices Market by Disease Pathology
6.3 Mexico Neurovascular Devices Market
6.3.1 Mexico Neurovascular Devices Market by End User
6.3.2 Mexico Neurovascular Devices Market by Technology
6.3.2.1 Mexico Neurovascular Devices Market by Embolization & Coiling Type
6.3.2.2 Mexico Neurovascular Devices Market by Neurothrombectomy Devices Type
6.3.2.3 Mexico Neurovascular Devices Market by Cerebral Balloon Angioplasty & Stenting Systems Type
6.3.2.4 Mexico Neurovascular Devices Market by Support Devices Type
6.3.3 Mexico Neurovascular Devices Market by Disease Pathology
6.4 Rest of North America Neurovascular Devices Market
6.4.1 Rest of North America Neurovascular Devices Market by End User
6.4.2 Rest of North America Neurovascular Devices Market by Technology
6.4.2.1 Rest of North America Neurovascular Devices Market by Embolization & Coiling Type
6.4.2.2 Rest of North America Neurovascular Devices Market by Neurothrombectomy Devices Type
6.4.2.3 Rest of North America Neurovascular Devices Market by Cerebral Balloon Angioplasty & Stenting Systems Type
6.4.2.4 Rest of North America Neurovascular Devices Market by Support Devices Type
6.4.3 Rest of North America Neurovascular Devices Market by Disease Pathology
Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Medtronic PLC
7.2.1 Company overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 SWOT Analysis
7.3 Stryker Corporation
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.4 Johnson & Johnson
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental & Regional Analysis
7.4.4 Research & Development Expenses
7.5 Terumo Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.6 Merit Medical Systems, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.7 MicroPort Scientific Corporation
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.8 Medikit Co. Ltd.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.9 W. L. Gore & Associates, Inc.
7.9.1 Company Overview
Unique Offerings 